AU2001250205A1 - Prostaglandin d2 receptor antagonists - Google Patents

Prostaglandin d2 receptor antagonists

Info

Publication number
AU2001250205A1
AU2001250205A1 AU2001250205A AU5020501A AU2001250205A1 AU 2001250205 A1 AU2001250205 A1 AU 2001250205A1 AU 2001250205 A AU2001250205 A AU 2001250205A AU 5020501 A AU5020501 A AU 5020501A AU 2001250205 A1 AU2001250205 A1 AU 2001250205A1
Authority
AU
Australia
Prior art keywords
prostaglandin
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250205A
Inventor
Marc Labelle
Bruno Roy
Claudio Sturino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of AU2001250205A1 publication Critical patent/AU2001250205A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
AU2001250205A 2000-04-12 2001-04-09 Prostaglandin d2 receptor antagonists Abandoned AU2001250205A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19631600P 2000-04-12 2000-04-12
US60196316 2000-04-12
PCT/CA2001/000490 WO2001079169A2 (en) 2000-04-12 2001-04-09 Prostaglandin d2 receptor antagonists

Publications (1)

Publication Number Publication Date
AU2001250205A1 true AU2001250205A1 (en) 2001-10-30

Family

ID=22724886

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250205A Abandoned AU2001250205A1 (en) 2000-04-12 2001-04-09 Prostaglandin d2 receptor antagonists

Country Status (4)

Country Link
US (1) US20010047027A1 (en)
AU (1) AU2001250205A1 (en)
CA (1) CA2405248A1 (en)
WO (1) WO2001079169A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038136A1 (en) 2002-01-24 2004-12-29 Merck Frosst Canada Inc CYCLALCANINDOLS WITH REPLACEMENT WITH FLUOR COMPOSITIONS CONTAINING THESE COMPOUNDS AND TREATMENT METHODS
EP1505061A4 (en) 2002-05-16 2007-08-22 Shionogi & Co Compound exhibiting pgd 2 receptor antagonism
KR20050111314A (en) 2002-12-20 2005-11-24 암젠 인코포레이션 Asthma and allergic inflammation modulators
AR041089A1 (en) * 2003-05-15 2005-05-04 Merck & Co Inc PROCEDURE AND PHARMACEUTICAL COMPOSITIONS TO TREAT ATEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED AFFECTIONS
PE20050483A1 (en) 2003-10-31 2005-08-25 Arena Pharm Inc TETRAZOLE DERIVATIVES OF FORMULA (I), ITS PHARMACEUTICAL COMPOSITIONS AND PROCESSES TO PRODUCE PHARMACEUTICAL COMPOSITIONS
US7019022B2 (en) * 2003-12-15 2006-03-28 Merck Frosst Canada & Co. Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
DE602005006539D1 (en) 2004-03-11 2008-06-19 Actelion Pharmaceuticals Ltd TETRAHYDROPYRIDOINDOLDERIVATE
WO2006052798A2 (en) * 2004-11-08 2006-05-18 Merck & Co., Inc. Method of treating pathological blushing
PE20060949A1 (en) 2004-12-23 2006-10-11 Arena Pharm Inc FUSED DERIVATIVES OF PIRAZOLE AS NIACIN RECEPTOR AGONISTS
NZ556657A (en) 2004-12-27 2010-10-29 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
JP5064219B2 (en) 2005-07-22 2012-10-31 塩野義製薬株式会社 Azaindoleic acid derivatives having PGD2 receptor antagonist activity
JP5072594B2 (en) 2005-07-22 2012-11-14 塩野義製薬株式会社 Indole derivatives having PGD2 receptor antagonist activity
WO2007029629A1 (en) 2005-09-06 2007-03-15 Shionogi & Co., Ltd. Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
EP2316824A1 (en) 2006-08-07 2011-05-04 Actelion Pharmaceuticals Ltd. (3-Amino-1,2,3,4-tetrahydro-9H-carbazoI-9-yl)-acetic acid derivates
ES2471919T3 (en) 2007-12-19 2014-06-27 Amgen, Inc Phenylacetic acid derivatives as inflammation modulators
ES2566739T3 (en) * 2008-02-01 2016-04-15 Brickell Biotech, Inc. Aminoalkylbiphenyl N, N-disubstituted prostaglandin D2 receptor antagonists
GB2460597B8 (en) * 2008-02-01 2014-03-12 Amira Pharmaceuticals Inc N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
WO2009102893A2 (en) * 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
EP2245022A4 (en) * 2008-02-25 2012-02-22 Panmira Pharmaceuticals Llc Antagonists of prostaglandin d2 receptors
US8426449B2 (en) * 2008-04-02 2013-04-23 Panmira Pharmaceuticals, Llc Aminoalkylphenyl antagonists of prostaglandin D2 receptors
KR101325367B1 (en) * 2008-07-03 2013-11-11 판미라 파마슈티칼스, 엘엘씨 Antagonists of prostaglandin d2 receptors
US8507473B2 (en) 2008-09-11 2013-08-13 Arena Pharmaceuticals, Inc. 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders
GB2463788B (en) * 2008-09-29 2010-12-15 Amira Pharmaceuticals Inc Heteroaryl antagonists of prostaglandin D2 receptors
WO2010042652A2 (en) 2008-10-08 2010-04-15 Amira Pharmaceuticals, Inc. Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
US20100173313A1 (en) * 2009-01-08 2010-07-08 Amira Pharmaceuticals, Inc. Biomarkers of inflammation
US8785393B2 (en) 2009-07-31 2014-07-22 Panmira Pharmaceuticals, Llc Ophthalmic pharmaceutical compositions of DP2 receptor antagonists
WO2011017201A2 (en) * 2009-08-05 2011-02-10 Amira Pharmaceuticals, Inc. Dp2 antagonist and uses thereof
WO2011085033A2 (en) 2010-01-06 2011-07-14 Amira Pharmaceuticals, Inc. Dp2 antagonist and uses thereof
CN102791689B (en) 2010-03-22 2014-10-29 埃科特莱茵药品有限公司 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin D2 receptor modulators
JP5964945B2 (en) 2011-04-14 2016-08-03 アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ 7- (Heteroaryl-amino) -6,7,8,9-tetrahydropyrido [1,2-a] indoleacetic acid derivatives and their use as prostaglandin D2 receptor modulators
MX368179B (en) 2014-03-17 2019-09-23 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators.
EP3119780B1 (en) 2014-03-18 2018-08-29 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
US20180021302A1 (en) * 2015-02-13 2018-01-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
EA035752B1 (en) 2015-09-15 2020-08-05 Идорсиа Фармасьютиклз Лтд CRYSTALLINE FORM OF (S)-2-(8-((5-CHLOROPYRIMIDIN-2-YL)(METHYL)AMINO)-2-FLUORO-6,7,8,9-TETRAHYDRO-5H-PYRIDO[3,2-b]INDOL-5-YL)ACETIC ACID AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use

Also Published As

Publication number Publication date
WO2001079169A3 (en) 2002-04-04
WO2001079169A2 (en) 2001-10-25
CA2405248A1 (en) 2001-10-25
US20010047027A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001250205A1 (en) Prostaglandin d2 receptor antagonists
AUPQ841800A0 (en) Truncated egf receptor
AUPR833401A0 (en) G protein-coupled receptor antagonists
AU2001273032A1 (en) Cytokine receptor zcytor17
AU2001264657A1 (en) Crf receptor antagonists
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
AU2001245724A1 (en) Il-8 receptor antagonists
AU2001240021A1 (en) Diazafluorenone il-8 receptor antagonists
AU2001243351A1 (en) Il-8 receptor antagonists
AU2002216079A1 (en) Bombesin receptor antagonists
AU2001240097A1 (en) G protein-coupled receptors
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists
AU2001249573A1 (en) Chemokine receptor antagonists
AU2001263288A1 (en) Crf receptor antagonists
AU2001253172A1 (en) Il-8 receptor antagonists
AU2001241896A1 (en) Il-8 receptor antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
AU2001223882A1 (en) Receptor
AUPQ563400A0 (en) Novel receptor
AU2001245605A1 (en) Il-8 receptor antagonists
AU2001249922A1 (en) G protein-coupled receptors
AU2574801A (en) Selective iGLUR5 receptor antagonists
AU1252102A (en) Receptor